DS
Therapeutic Areas
Gennova Bio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Elaxim® | Iron‑deficiency anemia | Approved |
| Hamsyl® | Renal anemia (EPO therapy) | Approved |
| Hamsyl® Junior | Pediatric renal anemia | Approved |
| PEGEX® | Enzyme replacement therapy (PEGylated) | Approved |
| Vintor® | Acute myocardial infarction | Approved |
| Xgrast® | Neutropenia (G‑CSF) | Approved |
| TENECTASE® | Acute ischemic stroke (3rd‑gen thrombolytic) | Approved |
| GEMCOVAC®‑OM | COVID‑19 vaccine (mRNA) | Phase 3 |